Effect of Prophylactic Percutaneous Endoscopic Gastrostomy on Postoperative Infection in Oral Cancer Patients Underwent Radical Resection along with Reconstruction

doi:10.13701/j.cnki.kqyxyj.2024.01.006

Abstract

Abstract: Objective: To investigate the effects of different types of enteral nutrition on surgical site infection after extensive resection and simultaneous reconstruction of patients with oral cancer. Methods: The data of patients who underwent oral cancer radical resection along with reconstruction at Oncological Department of Oral and Maxillofacial Surgery, the First Affiliated Hospital of Xinjiang Medical University from January 2018 to January 2023 were retrospectively analyzed. According to different enteral nutrition, the patients were divided into the group of prophylactic percutaneous endoscopic gastrostomy (26 cases), group of nasogastric tube (54 cases), and group of oral feeding (33 cases). The changes of postoperative surgical site infection rate and flap necrosis rate among three groups were analyzed through SPSS 25.0 statistical software. Results: The postoperative surgical site infection rate in the group treated with prophylactic percutaneous endoscopic gastrostomy was significantly lower than that in nasogastric tube group and oral feeding group (P<0.05). The rate of flap necrosis had no statistical significance among three groups (P>0.05). The difference of body mass index, total protein, albumin, creatinine, and hematocrit between admission and 6 weeks after surgery was significantly different among three groups (P<0.01). Conclusion: Prophylactic percutaneous endoscopic gastrostomy can effectively reduce the flap infection rate after extensive resection along with simultaneous reconstruction of oral cancer cases, which is worthy of clinical promotion.

Key words: oral cancer, repair and reconstruction, surgical site infection, prophylactic percutaneous endoscopic gastrostomy

Parekejiang·PATAER, LI Chenxi, Keremu·ABASI, HU Lulu, FANG Chang, GONG Zhongcheng. Effect of Prophylactic Percutaneous Endoscopic Gastrostomy on Postoperative Infection in Oral Cancer Patients Underwent Radical Resection along with Reconstruction[J]. Journal of Oral Science Research, 2024, 40(1): 29-34.

References

[1] Li CX, Liu H, Gong ZC. What is the potential interplay between microbiome and tumor microenvironment in oral squamous cell carcinomas? [J]. Asian Pac J Cancer Prev, 2022, 23(7):2199-2213.
[2] Chamoli A, Gosavi AS, Shirwadkar UP, et al. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics [J]. Oral Oncol, 2021, 121:105451.
[3] Li CX, Sun JL, Gong ZC, et al. An umbrella review exploring the effect of radiotherapy for head and neck cancer patients on the frequency of jaws osteoradionecrosis [J]. Cancer Radiother, 2023, 27(5):434-446.
[4] Li CX, Gong ZC, Tan XR. Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma [J]. Cancer Immunol Immunother, 2023, 72(9):3133-3134.
[5] Li CX, Wei W, Li MQ, et al. Letter to the editor about the article published in clinical oral investigations titled "The contralateral-based submental artery island flap: feasibility and oncological safety in oral cancer-related defect reconstruction" (Ma J, Zhai X, Huang M, Li P, Liang Y, Ouyang D, Su YX, Yang WF, Liao G, Zhang S. Clin Oral Investig, https://doi.org/10.1007/s00784-023-05103-1) [J]. Clin Oral Investig, 2023, 27(10):6273-6275.
[6] Yuwanati M, Gondivkar S, Sarode SC, et al. Oral health-related quality of life in oral cancer patients: systematic review and meta-analysis [J]. Future Oncol, 2021, 17(8):979-990.
[7] Gharat SA, Momin M, Bhavsar C. Oral squamous cell carcinoma: Current treatment strategies and nanotechnology-based approaches for prevention and therapy [J]. Crit Rev Ther Drug Carrier Syst, 2016, 33(4):363-400.
[8] Li C, Shi W, Gong Z, et al. Anterolateral thigh perforator flap made by customized 3D-printing fabrication of fixed positioning guide for oromaxillofacial reconstruction: a preliminary study [J]. Med Oral Patol Oral Cir Bucal, 2023, 28(1):e41-e47.
[9] 黄志权.口腔癌术后缺损修复的研究进展[J].实用医学杂志,2021,37(1):1-5.
[10] Cannon RB, Houlton JJ, Mendez E, et al. Methods to reduce postoperative surgical site infections after head and neck oncology surgery [J]. Lancet Oncol, 2017, 18(7):e405-e413.
[11] 苏俊琪,宋扬,谢尚.口腔鳞状细胞癌患者修复重建术后感染的病原学特征及感染风险预测模型的构建[J].北京大学学报:医学版,2022,54(1):68-76.
[12] Lin SC, Chang TS, Yang KC, et al. Factors contributing to surgical site infection in patients with oral cancer undergoing microvascular free flap reconstruction [J]. Eur Arch Otorhinolaryngol, 2018, 275(8):2101-2108.
[13] Belusic-Gobic M, Zubovic A, Cerovic R, et al. Multivariate analysis of risk factors for postoperative wound infection following oral and oropharyngeal cancer surgery [J]. J Craniomaxillofac Surg, 2018, 46(1):135-141.
[14] Din-Lovinescu C, Barinsky GL, Povolotskiy R, et al. Percutaneous endoscopic gastrostomy tube timing in head and neck cancer surgery [J]. Laryngoscope, 2023, 133(1):109-115.
[15] 卢倩,郭柳媚,毕小琴.口腔癌患者术后吞咽障碍危险因素的系统评价[J].华西口腔医学杂志,2022,40(3):328-334.
[16] Dechaphunkul T, Soonthornrak P, Geater SL, et al. Utility of prophylactic percutaneous endoscopic gastrostomy tube in head and neck cancer patients undergoing concurrent chemoradiation: A prospective observational cohort [J]. Am J Otolaryngol, 2022, 43(4):103512.
[17] de Almeida JR, Yao CMKL, Ziai H, et al. Postoperative wound infections, neutrophil-to-lymphocyte ratio, and cancer recurrence in patients with oral cavity cancer undergoing surgical resection [J]. Oral Oncol, 2019, 97:23-30.
[18] Mascarella MA, Azzi JL, da Silva SD, et al. Postoperative infection predicts poor survival in locoregionally advanced oral cancer [J]. Head Neck, 2019, 41(10):3624-3630.
[19] Gondo T, Fujita K, Nagafuchi M, et al. The effect of preventive oral care on postoperative infections after head and neck cancer surgery [J]. Auris Nasus Larynx, 2020, 47(4):643-649.
[20] Karthik K, Dhiwakar M. Predictors of surgical site infection and pneumonia following oral cavity tumor surgery [J]. Head Neck, 2021, 43(10):3106-3115.
[21] 张建丽,刘玉坤,任起辉,等.行口腔颌面外科术患者术后感染病原学特征及相关因素分析[J].中华医院感染学杂志,2018,28(3):440-443.
[22] Makiguchi T, Yokoo S, Kanno Y, et al. Risk factors for surgical site infection in patients undergoing free and pedicled myocutaneous flap reconstruction after oral cancer resection [J]. J Oral Maxillofac Surg, 2019, 77(5):1075-1081.
[23] Karakida K, Aoki T, Ota Y, et al. Analysis of risk factors for surgical-site infections in 276 oral cancer surgeries with microvascular free-flap reconstructions at a single university hospital [J]. J Infect Chemother, 2010, 16(5):334-339.
[24] Kamizono K, Sakuraba M, Nagamatsu S, et al. Statistical analysis of surgical site infection after head and neck reconstructive surgery [J]. Ann Surg Oncol, 2014, 21(5):1700-1705.
[25] Lee DH, Kim SY, Nam SY, et al. Risk factors of surgical site infection in patients undergoing major oncological surgery for head and neck cancer [J]. Oral Oncol, 2011, 47(6):528-531.
[26] Sandmael JA, Sand K, Bye A, et al. Nutritional experiences in head and neck cancer patients [J]. Eur J Cancer Care (Engl), 2019, 28(6):e13168.
[27] Udd M, Lindström O, Mustonen H, et al. Assessment of indications for percutaneous endoscopic gastrostomy-development of a predictive model [J]. Scand J Gastroenterol, 2015, 50(2):245-252.
[28] Groeger SE, Meyle J. Epithelial barrier and oral bacterial infection [J]. Periodontol 2000, 2015, 69(1):46-67.
[29] Tabrizi R, Hosseinpour S, Taghizadeh F. Feeding in oral cancer patients after massive ablative surgery: Percutaneous endoscopic gastrostomy or nasogastric tube [J]. J Craniofac Surg, 2016, 27(4):1010-1011.
[30] Löser C, Aschl G, Hébuterne X, et al. ESPEN guidelines on artificial enteral nutrition--percutaneous endoscopic gastrostomy (PEG) [J]. Clin Nutr, 2005, 24(5):848-861.
[31] Yanni A, Dequanter D, Lechien JR, et al. Malnutrition in head and neck cancer patients: Impacts and indications of a prophylactic percutaneous endoscopic gastrostomy [J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2019, 136(3S):S27-S33.
[32] Russo G, Haddad R, Posner M, et al. Radiation treatment breaks and ulcerative mucositis in head and neck cancer [J]. Oncologist, 2008, 13(8):886-898.
[33] Langius JA, Zandbergen MC, Eerenstein SE, et al. Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo)radiotherapy: a systematic review [J]. Clin Nutr, 2013, 32(5):671-678.
[34] Salas S, Baumstarck-Barrau K, Alfonsi M, et al. Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: Prospective randomized trial [J]. Radiother Oncol, 2009, 93(3):503-509.
[35] 钱立,葛奎,徐兵,等.预防性经皮内镜胃造瘘术在接受放化疗的头颈部肿瘤患者中的应用[J].中国口腔颌面外科杂志,2018,6(2):167-170.
[36] Ishimaru M, Ono S, Suzuki S, et al. Risk factors for free flap failure in 2,846 patients with head and neck cancer: A national database study in Japan [J]. J Oral Maxillofac Surg, 2016, 74(6):1265-1270.
[37] Marttila E, Thorén H, Törnwall J, et al. Complications and loss of free flaps after reconstructions for oral cancer [J]. Br J Oral Maxillofac Surg, 2018, 56(9):835-840.
[38] Wang C, Fu G, Liu F, et al. Perioperative risk factors that predict complications of radial forearm free flaps in oral and maxillofacial reconstruction [J]. Br J Oral Maxillofac Surg, 2018, 56(6):514-519.
[39] Chotipanich A, Wongmanee S. The infrahyoid myocutaneous flap for reconstruction after oral cancer resection: A retrospective single-surgeon study [J]. World J Otorhinolaryngol Head Neck Surg, 2018, 4(4):273-277.
[40] Knitschke M, Sonnabend S, Bäcker C, et al. Partial and total flap failure after fibula free flap in head and neck reconstructive surgery: Retrospective analysis of 180 flaps over 19 years [J]. Cancers (Basel), 2021, 13(4):865.